Correlation Between Hepion Pharmaceuticals and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Relay Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Relay Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Relay Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Hepion and Relay is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Relay Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 1.86 times more return on investment than Relay Therapeutics. However, Hepion Pharmaceuticals is 1.86 times more volatile than Relay Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 65.00 in Hepion Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 1.00 from holding Hepion Pharmaceuticals or generate 1.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Relay Therapeutics
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Relay Therapeutics |
Hepion Pharmaceuticals and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Relay Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |